These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1714884)

  • 1. Characterization of the new bladder cancer cell line HOK-1: expression of transitional, squamous and glandular differentiation patterns.
    Offner FA; Ott G; Povey S; Knuechel R; Preisler V; Fuezesi L; Klosterhalfen B; Ruebben H; Hofstaedter F; Kirkpatrick CJ
    Int J Cancer; 1991 Aug; 49(1):122-8. PubMed ID: 1714884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation.
    Russell PJ; Jelbart M; Wills E; Singh S; Wass J; Wotherspoon J; Raghavan D
    Int J Cancer; 1988 Jan; 41(1):74-82. PubMed ID: 3335421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
    Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
    Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cell lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL-13.
    Russell PJ; Wass J; Lukeis R; Garson OM; Jelbart M; Wills E; Philips J; Brown J; Carrington N; Vincent PC
    Int J Cancer; 1989 Aug; 44(2):276-85. PubMed ID: 2759734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The L1 antigen and squamous metaplasia in the bladder.
    Tungekar MF; Heryet A; Gatter KC
    Histopathology; 1991 Sep; 19(3):245-50. PubMed ID: 1717359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas.
    Harnden P; Southgate J
    J Clin Pathol; 1997 Dec; 50(12):1032-3. PubMed ID: 9516889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice.
    Reid LM; Leav I; Kwan PW; Russell P; Merk FB
    Cancer Res; 1984 Oct; 44(10):4560-73. PubMed ID: 6467211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity.
    Brown JL; Russell PJ; Philips J; Wotherspoon J; Raghavan D
    Br J Cancer; 1990 Mar; 61(3):369-76. PubMed ID: 2328200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
    Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
    J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a new cell line from human bladder cancer (JMSU1).
    Morita T; Shinohara N; Honma M; Tokue A
    Urol Res; 1995; 23(3):143-9. PubMed ID: 7483139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a cell line (CUMC-3) derived from a human squamous carcinoma of the uterine cervix.
    Kim JW; Cho YH; Lyu MS; Lee CG; Jung JK; Kim SJ; Namkoong SE
    Gynecol Oncol; 1995 Apr; 57(1):47-60. PubMed ID: 7705700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urothelial carcinoma with squamous differentiation--the pathologists׳ perspective.
    Gellert LL; Warrick J; Al-Ahmadie HA
    Urol Oncol; 2015 Oct; 33(10):437-43. PubMed ID: 26321057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive carcinoma in bladder exstrophy with transitional, squamous and mucus-producing differentiation.
    Vik V; Gerharz EW; Woodhouse CR
    Br J Urol; 1998 Jan; 81(1):173-4. PubMed ID: 9467503
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladder.
    Adam RM; DeGraff DJ
    Urol Oncol; 2015 Oct; 33(10):444-50. PubMed ID: 26254697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal abnormalities in two bladder carcinomas with secondary squamous cell differentiation.
    Fadl-Elmula I; Gorunova L; Lundgren R; Mandahl N; Forsby N; Mitelman F; Heim S
    Cancer Genet Cytogenet; 1998 Apr; 102(2):125-30. PubMed ID: 9546064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive production of multiple cytokines and a human chorionic gonadotrophin beta-subunit by a human bladder cancer cell line (KU-19-19): possible demonstration of totipotential differentiation.
    Tachibana M; Miyakawa A; Nakashima J; Murai M; Nakamura K; Kubo A; Hata JI
    Br J Cancer; 1997; 76(2):163-74. PubMed ID: 9231915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
    Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
    Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests.
    Friedrich MG; Hellstern A; Hautmann SH; Graefen M; Conrad S; Huland E; Huland H
    J Urol; 2002 Aug; 168(2):470-4. PubMed ID: 12131290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.